Paid Epilepsy Clinical Trials
Epilepsy clinical trials recruiting. Access new anti-seizure medications. Compensation up to $3,000 for adults with uncontrolled seizures.
Compensation
$1,500 - $3,000
Duration
16-52 weeks
Phase
Phase II/III
FDA Regulated
IRB Approved
GCP Certified
Who May Qualify
- Age 18-70 years
- Diagnosis of epilepsy with focal or generalized seizures
- At least 4 countable seizures per month despite 1-3 anti-seizure medications
- Stable anti-seizure medication regimen for at least 4 weeks
- Ability to maintain accurate seizure diary
- No planned changes to current therapy
Who May Not Qualify
- Non-epileptic seizures (psychogenic)
- Status epilepticus in past 12 months
- Prior epilepsy surgery
- Active vagus nerve stimulator or RNS device
- History of poor medication compliance
Frequently Asked Questions
What epilepsy treatments are being studied?
+
Studies are evaluating new anti-seizure medications with novel mechanisms, treatments for specific epilepsy syndromes, and adjunctive therapies for drug-resistant epilepsy.
How do I track seizures during the study?
+
You will maintain a daily seizure diary (usually electronic) recording seizure type, time, duration, and any triggers. Accurate diary completion is critical for measuring treatment response.
Can I continue my current seizure medications?
+
Yes, most studies are "add-on" trials where the study drug is added to your current regimen. Keeping your baseline medications stable helps assess whether the new treatment provides additional benefit.
What if my seizures worsen during the study?
+
Your safety is prioritized. If seizures significantly worsen, the study team can adjust treatment or withdraw you from the study to ensure appropriate medical care.